Primary Site >> Liver Cancer
Gene >> CD5L
|
|
|
|
|
|---|---|---|---|---|
|
Ref: A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease. PMID: 19656391 |
Ref: Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study. PMID: 24066001 |
Ref: Dietary fructose-induced hepatocellular carcinoma development manifested in mice lacking apoptosis inhibitor of macrophage (AIM). PMID: 27813205 |
Ref: Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS). PMID: 28550167 Ref: Apoptosis inhibitor of macrophage ameliorates fungus-induced peritoneal injury model in mice. PMID: 28743989 |
Ref: CD5L is upregulated in hepatocellular carcinoma and promotes liver cancer cell proliferation and antiapoptotic responses by binding to HSPA5 (GRP78). PMID: 29465313 Ref: Independent modes of disease repair by AIM protein distinguished in AIM-felinized mice. PMID: 30177770 |